Data / Form D filings / TVAX Biomedical, Inc.
TVAX Biomedical, Inc.: Form D filings
TVAX Biomedical, Inc., a biotechnology company in Olathe, KS, filed 3 Form D notices with the SEC between 2011 and 2016. The latest, on July 7, 2016, reports $325,075 sold of a $500,000 offering to 14 investors.
Find out what TVAX Biomedical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10900 S. Clay Blair Blvd., Suite 700, Olathe, KS, 66061
- Phone
- (913) 689-2953
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1526959
The full lists. Form D filings in Kansas: 193 rows, $9.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2016 | New notice | $500,000 | $325,075 | $174,925 | 14 | Jun 23, 2016 | sec.gov |
| Dec 13, 2012 | New notice | $6,048,000 | $2,027,318 | $4,020,682 | 29 | Nov 28, 2012 | sec.gov |
| Jul 29, 2011 | New notice | Indefinite | $0 | Indefinite | 135 | Jul 15, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Barry S. Skikne | Director | |
| Charles W. Burton | Director | |
| Tammie A. Wahaus | Executive Officer | |
| Lowell L. Tilzer | Executive Officer, Director | |
| Catherine E. Lucasey | Executive Officer, Director | |
| Wesley E. Griffitt | Director | |
| Gary W. Wood | Director |
Every Form D from the week of Jul 4, 2016 · All recent filings in Kansas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TVAX Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.